94.87
+12.31
+(14.91%)
At close: January 10 at 4:00:02 PM EST
95.16
+0.29
+(0.31%)
After hours: January 10 at 5:21:55 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-62,160.00
-124,199.00
-270,186.00
-259,544.00
-230,073.00
Investing Cash Flow
-137,836.00
105,541.00
-128,373.00
280,344.00
-480,295.00
Financing Cash Flow
564,906.00
17,810.00
455,159.00
11,519.00
664,177.00
End Cash Position
466,062.00
149,517.00
150,365.00
93,765.00
61,446.00
Income Tax Paid Supplemental Data
1,526.00
162.00
6.00
6.00
2.00
Capital Expenditure
-750.00
-269.00
-778.00
-325.00
-267.00
Issuance of Capital Stock
543,086.00
--
433,718.00
--
652,712.00
Free Cash Flow
-62,910.00
-124,468.00
-270,964.00
-259,869.00
-230,340.00
12/31/2020 - 1/7/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NBIX Neurocrine Biosciences, Inc.
140.90
+1.58%
ALKS Alkermes plc
28.08
-1.20%
LNTH Lantheus Holdings, Inc.
95.88
+2.00%
KNSA Kiniksa Pharmaceuticals International, plc
19.93
-1.82%
AVDL Avadel Pharmaceuticals plc
7.90
-26.10%
AQST Aquestive Therapeutics, Inc.
3.0800
-1.60%
BHC Bausch Health Companies Inc.
7.88
+0.64%
DERM Journey Medical Corporation
3.8300
-4.25%
EOLS Evolus, Inc.
10.00
-2.06%
ETON Eton Pharmaceuticals, Inc.
13.44
+11.91%